Dr. Wiernik is Director of the Leukemia Program at St. Luke's Roosevelt Hospital and Beth Israel Medical Center in manhattan. In addition to treating patients with all hematologic malignancies, he conducts research into various aspects of those illnesses. AT present he and his team are exploring genetic explanations for familial hematologic malignancies.
ServicesAll FDA-approved cancer treatments are available at these institutions. In addition, Dr. Wiernik is engaged in a number of clinical trial and other clinical investigations sponsored by the pharmaceutical industry as well as the national Cancer Institute.